Published in Cancer Weekly, June 10th, 2003
Correlogic's test, called Proteome Pattern Blood Test, scans a drop of blood for protein patterns generated by a mass spectrometer. In February 2002, Correlogic Systems earned international recognition when its joint research with the National Cancer Institute (NCI) and the U.S. Food and Drug Administration (FDA) revealed that the Correlogic test successfully detected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.